Exercise in Diabetic Nephropathy: Protective Effects and Molecular Mechanism

被引:7
|
作者
Li, Ruo-Ying [1 ,2 ,3 ]
Guo, Liang [1 ,2 ,3 ]
机构
[1] Shanghai Univ Sport, Collaborat Innovat Ctr Sports & Publ Hlth, Sch Exercise & Hlth, Shanghai 200438, Peoples R China
[2] Shanghai Univ Sport, Shanghai Frontiers Sci Res Base Exercise & Metab H, Shanghai 200438, Peoples R China
[3] Shanghai Univ Sport, Key Lab Exercise & Hlth Sci, Minist Educ, Shanghai 200438, Peoples R China
关键词
diabetic nephropathy; exercise; AMPK; Sirt1; renin-angiotensin system; MicroRNAs; nitric oxide; heat shock protein; exerkine; metabolites; gut microbiota; CHRONIC KIDNEY-DISEASE; GLYCATION END-PRODUCTS; OXIDATIVE STRESS; NITRIC-OXIDE; BETA-HYDROXYBUTYRATE; PHYSICAL-ACTIVITY; IL-6; RELEASE; INFLAMMATION; RECEPTOR; PATHWAY;
D O I
10.3390/ijms25073605
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetic nephropathy (DN) is a serious complication of diabetes, and its progression is influenced by factors like oxidative stress, inflammation, cell death, and fibrosis. Compared to drug treatment, exercise offers a cost-effective and low-risk approach to slowing down DN progression. Through multiple ways and mechanisms, exercise helps to control blood sugar and blood pressure and reduce serum creatinine and albuminuria, thereby alleviating kidney damage. This review explores the beneficial effects of exercise on DN improvement and highlights its potential mechanisms for ameliorating DN. In-depth understanding of the role and mechanism of exercise in improving DN would pave the way for formulating safe and effective exercise programs for the treatment and prevention of DN.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] Exercise in Diabetic Cardiomyopathy: Its Protective Effects and Molecular Mechanism
    Chen, Humin
    Guo, Liang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (04)
  • [2] Molecular mechanism of diabetic nephropathy
    Lehmann, R
    Schleicher, ED
    CLINICA CHIMICA ACTA, 2000, 297 (1-2) : 135 - 144
  • [3] The Molecular Mechanism of Rhein in Diabetic Nephropathy
    Zeng, Cong-Cong
    Liu, Xi
    Chen, Guo-Rong
    Wu, Qian-Jia
    Liu, Wang-Wang
    Luo, Hai-Ying
    Cheng, Jin-Guo
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
  • [4] An examination of the protective effects and molecular mechanisms of curcumin, a polyphenol curcuminoid in diabetic nephropathy
    Zhu, Xiaoyu
    Xu, Xingli
    Du, Chigang
    Su, Yanping
    Yin, Lixue
    Tan, Xiaoqiu
    Liu, Hui
    Wang, Yiru
    Xu, Lei
    Xu, Xinghua
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
  • [5] Protective effects of lithospermate B on diabetic nephropathy
    Lee, GT
    Chung, MG
    Ahn, CW
    Ha, HJ
    Lee, HC
    DIABETOLOGIA, 2001, 44 : A265 - A265
  • [6] Protective Effects of Oxymatrine on Experimental Diabetic Nephropathy
    Guo, Changrun
    Han, Fengyu
    Zhang, Chunfeng
    Xiao, Wei
    Yang, Zhonglin
    PLANTA MEDICA, 2014, 80 (04) : 269 - 276
  • [7] SIRT1: Mechanism and Protective Effect in Diabetic Nephropathy
    Ji, Jing
    Tao, Pengyu
    Wang, Qian
    Li, Lingxing
    Xu, Yuzhen
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2021, 21 (05) : 835 - 842
  • [8] Update on the Protective Renal Effects of Metformin in Diabetic Nephropathy
    Eisenreich, Andreas
    Leppert, Ulrike
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (31) : 3397 - 3412
  • [9] EXAMINATION OF THE PROTECTIVE EFFECTS OF PACAP IN RAT DIABETIC NEPHROPATHY
    Nagy, D.
    Banki, E.
    Csanaky, K.
    Duh, A.
    Kovacs, K.
    Kemeny, A.
    Kiss, P.
    Tamas, A.
    Degrell, P.
    Szakaly, P.
    Jancso, G.
    Toth, G.
    Reglodi, D.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 51 : S188 - S189
  • [10] Protective effects of aliskiren and valsartan in mice with diabetic nephropathy
    Wang, Weidong
    Qiu, Liru
    Howard, Allison
    Solis, Nathaniel
    Li, Chunling
    Wang, Xiaoxin
    Kopp, Jeffrey B.
    Levi, Moshe
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2014, 15 (04) : 384 - 395